In silico ADMET study, docking, synthesis and antimalarial evaluation of thiazole-1,3,5-triazine derivatives as Pf-DHFR inhibitor

WHO fact-sheets on malaria. 2018. (Assessed 22 December 2018) https://www.who.int/news-room/fact-sheets/detail/malaria.

Lichtenberg, 2005

Craft, 2008, Challenges facing drug development for malaria, Curr Opin Microbiol, 11, 428, 10.1016/j.mib.2008.09.003

White, 2011, Costs and cost-effectiveness of malaria control interventions—a systematic review, Malar J, 10, 337, 10.1186/1475-2875-10-337

Price, 2014, Global extent of chloroquine-resistant Plasmodium vivax: a systematic review and meta-analysis, Lancet Infect Dis, 14, 982, 10.1016/S1473-3099(14)70855-2

Hanboonkunupakarn, 2016, The threat of antimalarial drug resistance, Trop Dis Travel Med Vaccines, 2, 10, 10.1186/s40794-016-0027-8

Anvikar, 2012, In vitro assessment of drug resistance in Plasmodium falciparum in five States of India, Indian J Med Res, 135, 494

Dondorp, 2009, Artemisinin resistance in Plasmodium falciparum malaria, N Engl J Med, 361, 455, 10.1056/NEJMoa0808859

Ashley, 2018, Drugs in development for malaria, Drugs, 78, 861, 10.1007/s40265-018-0911-9

Schuhmacher, 2016, Changing R&D models in research-based pharmaceutical companies, J Transl Med, 14, 105, 10.1186/s12967-016-0838-4

Nzila, 2006, Inhibitors of de novo folate enzymes in Plasmodium falciparum, Drug Discov Today, 11, 939, 10.1016/j.drudis.2006.08.003

Toyoda, 1997, Lead discovery of inhibitors of the dihydrofolate reductase domain of Plasmodium falciparum dihydrofolate reductasethymidylate synthase, Biochem Biophys Res Commun, 235, 515, 10.1006/bbrc.1997.6814

Sahu, 2016, Microwave assisted synthesis, antimalarial screening and structure–activity-relationship exploration of some phenylthiazolyl-triazine derivatives against dihydrofolate reductase, Med Chem Res, 25, 2916, 10.1007/s00044-016-1714-8

Sahu, 2016, Design, synthesis and antimalarial screening of some hybrid 4-aminoquinoline-triazine derivatives against pf-DHFR-TS, Exp Parasitol, 163, 45, 10.1016/j.exppara.2016.01.010

Gahtori, 2016, Toward resistance-compromised DHFR inhibitors part 1: combined structure/ligand-based virtual screenings and ADME-Tox profiling, J Chemom, 30, 462, 10.1002/cem.2814

Reaume, 2012, Drug repurposing through nonhypothesis driven phenotypic screening, Drug Discov Today Ther Strateg, 8, 85, 10.1016/j.ddstr.2011.09.007

Rieckmann, 1978, Drug sensitivity of P. falciparum: an in vitro microtechnique, Lancet, 311, 22, 10.1016/S0140-6736(78)90365-3

Egan, 2002, Prediction of intestinal permeability, Adv Drug Del Rev, 54, 273, 10.1016/S0169-409X(02)00004-2

Cheng, 2003, Prediction of aqueous solubility of a diverse set of compounds using quantitative structure-property relationships, J Med Chem, 46, 3572, 10.1021/jm020266b

Gahtori, 2012, Antimalarial evaluation and docking studies of hybrid phenylthiazolyl-1,3,5-triazine derivatives: A novel and potential antifolate lead for Pf-DHFR-TS inhibition, Exp Parasitol, 130, 292, 10.1016/j.exppara.2011.12.014